Recent research by the National Institutes of Health’s Center for Cancer Research found that injected neon green spray actually helps doctors find even the smallest cancerous tumors that often are missed through more traditional methods like magnetic resonance imaging (MRI).

Though the research sounds more like science fiction rather than science fact, this new system will revolutionize cancer medicine. However, the research was limited to peritoneal ovarian cancer in lab mice, but the implications for all types of cancers, including malignant mesothelioma, are numerous.

This spray is actually a Food and Drug Administration-approved, non-hazardous “fluorescence agent” known as indocyanine green covers cancerous material, including cells, tumors and nodules, allowing MRIs and other imaging machines to capture crystal clear pictures of the area.

The Revolutionary Neon Green Spray

Clearly, the application of the intravenous indocyanine green in cancer patients means that surgeons will be able to perform more precise and exacting surgeries, possibly eliminating the need for multiple surgeries.
Chemotherapy and radiation treatments will also become highly targeted. If doctors are able to pinpoint the exact location of cancerous tumors that are out of reach of surgeons’ scalpels, then these patients may not need to receive hazardous levels of radiation and chemotherapy.

Further, the use of indocyanine green will also limit the amount of time spent in MRIs and other imaging machines. Both doctors and patients will gain a much more thorough and comprehensive view of the cancer.
The use of the neon green spray in conjunction with MRIs may aid in the cancer staging process, overall treatment plans, prognoses and recovery times.

For patients suffering from a lethal cancer like mesothelioma, the staging process is incredibly complex. Earlier staging usually equals more longevity. Essentially, if a patient is diagnosed with an earlier stage of mesothelioma, the treatment options widen.

Even more, with the use of the indocyanine, spray may help doctors evaluate individuals at a higher risk of developing mesothelioma before any signs or symptoms begin. The neon green spray may also revolutionize the way that doctors screen for cancer, allowing for earlier and earlier detection.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.